Vaccine Articles | Global Biodefense

Many Flu Strains May Be Capable of Mutating to Escape Universal-Vaccine Antibodies

Funding for Preclinical Development of Countermeasures Against Select Pathogens
Promising Results from Phase 1 Trial of Equine Encephalitis Virus Vaccine
AstraZeneca Teams with Oxford Biomedica to Shore Up COVID-19 Vaccine Manufacturing Capacity

GSK Announces Plans to Produce 1 Billion Doses of Pandemic Vaccine Adjuvant in 2021

by Global Biodefense Staff May 28, 2020, 9:03 am
Thailand Begins Coronavirus Vaccine Trials on Monkeys

by Global Biodefense Staff May 23, 2020, 4:10 pm
First Human Trial of COVID-19 Vaccine Finds it is Safe and Induces Rapid Immune Response

by Global Biodefense Staff May 22, 2020, 2:22 pm
‘Dirty Mice’ Could Help Make a More Effective Flu Vaccine

by Global Biodefense Staff May 12, 2020, 8:00 am
The Challenges of Developing a Safe and Effective COVID-19 Vaccine

by Global Biodefense Staff May 12, 2020, 1:00 am
Inactivated Vaccine Candidate Protects Macaques From SARS-Cov-2 Infection

by Global Biodefense Staff May 6, 2020, 10:00 am
NYU Langone Health Enrolling Patients in US Clinical Trial For COVID-19 mRNA Vaccine

by Global Biodefense Staff May 5, 2020, 8:00 am
Promising MERS Coronavirus Vaccine Trial in Humans

by Global Biodefense Staff April 22, 2020, 3:00 pm
Emergex and GMU’s National Center for Biodefense and Infectious Diseases Partner for Highly Pathogenic RNA Virus Studies

by Global Biodefense Staff April 22, 2020, 9:00 am
Researchers Develop New Microneedle Array Combination Vaccine Delivery System

by Global Biodefense Staff April 21, 2020, 9:00 am
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
Investigational Chimp Adenovirus MERS-CoV Vaccine Protects Monkeys

by Global Biodefense Staff April 17, 2020, 3:00 am
New Universal Ebola Vaccine May Fight All Four Virus Species that Infect Humans

by Global Biodefense Staff April 16, 2020, 11:15 am
Inside the Effort to Repurpose a Manufacturing Platform to Produce COVID-19 Vaccines

by Alan Rudolph and Raymond P. Goodrich, Colorado State University April 15, 2020, 10:31 am
INOVIO Initiates Phase 1 Clinical Trial of COVID-19 Vaccine Candidate

by Global Biodefense Staff April 7, 2020, 11:27 am

Congratulations. You've reached the end of the internet.

Vaccines

Many Flu Strains May Be Capable of Mutating to Escape Universal-Vaccine Antibodies

Funding for Preclinical Development of Countermeasures Against Select Pathogens

Promising Results from Phase 1 Trial of Equine Encephalitis Virus Vaccine

AstraZeneca Teams with Oxford Biomedica to Shore Up COVID-19 Vaccine Manufacturing Capacity

GSK Announces Plans to Produce 1 Billion Doses of Pandemic Vaccine Adjuvant in 2021

Thailand Begins Coronavirus Vaccine Trials on Monkeys

First Human Trial of COVID-19 Vaccine Finds it is Safe and Induces Rapid Immune Response

‘Dirty Mice’ Could Help Make a More Effective Flu Vaccine

The Challenges of Developing a Safe and Effective COVID-19 Vaccine

Inactivated Vaccine Candidate Protects Macaques From SARS-Cov-2 Infection

NYU Langone Health Enrolling Patients in US Clinical Trial For COVID-19 mRNA Vaccine

Promising MERS Coronavirus Vaccine Trial in Humans

Emergex and GMU’s National Center for Biodefense and Infectious Diseases Partner for Highly Pathogenic RNA Virus Studies

Researchers Develop New Microneedle Array Combination Vaccine Delivery System

Investigational Chimp Adenovirus MERS-CoV Vaccine Protects Monkeys

New Universal Ebola Vaccine May Fight All Four Virus Species that Infect Humans

Inside the Effort to Repurpose a Manufacturing Platform to Produce COVID-19 Vaccines

INOVIO Initiates Phase 1 Clinical Trial of COVID-19 Vaccine Candidate

The Role Nuclear-Related Techniques Play in Fighting Zoonotic Diseases

Relief Funds Being Used to Pay Hospital Shareholders at the Expense of Frontline Health Care Workers

The U.S. Isn’t In a Second Wave of Coronavirus – the First Wave Never Ended

Coronavirus Can Cause Lasting Lung Damage – But the Effects May Ease Over Time

Researchers Identify Multiple Molecules that Shut Down SARS-Cov-2 Polymerase Reaction

Bioxy Decontaminant Agent Tested by DoD Shown Effective Against COVID-19

Air Force COVID-19 Medical Transport: Portable Biocontainment Care Module

CCDC Chemical Biological Center Strives to Become DoD’s Biomanufacturing Leader

Air Force Bioenvironmental Engineers Expand Mission in Aerovac, Close Workspaces

Rapid-Release Gases to Speed Up Cleaning of COVID-19 Ambulances

Chasing the Antidote for Deadly Nerve Agents

Latest stories

Latest Articles